Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Primary Healthcare Services01:30

Primary Healthcare Services

1.9K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.9K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

14.1K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
14.1K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

439
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
439
Healthcare Agencies II01:17

Healthcare Agencies II

1000
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
1000
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Associations of Anthropometry Measures Across 35 Years With Late-Life Plasma P-tau217 and Dementia: The HUNT Study.

Neurology·2026
Same author

Cultural and linguistic adaptation and delivery of START (STrAtegies for RelaTives) for caregivers of people with dementia in India: a mixed method study.

Aging & mental health·2026
Same author

The policy exposome of dementia: Gaps, opportunities, and research agenda.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

The DREAMS START intervention for sleep in dementia: Long-term follow-up of a randomized controlled trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

TaIlored ManagEment of Sleep (TIMES) for people with dementia and mild cognitive impairment in primary care in England: protocol for a feasibility cluster-randomised controlled trial.

Pilot and feasibility studies·2026
Same author

Predicting cognitive decline: Comparative analysis of ANU-ADRI, CAIDE, CogDrisk, LIBRA, LIBRA2, UKBDRS and Lancet based dementia risk scores in the HUNT study.

The journal of prevention of Alzheimer's disease·2026

関連する実験動画

Updated: Jan 8, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
10:57

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children

Published on: August 22, 2012

24.2K

公衆衛生

Esther K Hui1, Naheed Mukadam2, Gianna Kohl1

  • 1University College London, London, United Kingdom.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 23, 2025
PubMed
まとめ

一部の糖尿病薬は認知症のリスクを低減する可能性があります。グルカゴン様ペプチド-1受容体作動薬（GLP-1 RA）とグリタゾンは保護効果を示しますが、メトホルミンなどは認知機能低下の予防において一貫性のない結果を示しています。

科学分野:

  • 内分泌学
  • 神経科学
  • 薬理学

背景:

  • 糖尿病は認知症の重要なリスク因子である。
  • 様々な糖尿病治療薬が認知症リスクに及ぼす特定の影響は不明なままである。

研究 の 目的:

  • 糖尿病治療薬が認知症、軽度認知障害（MCI）、認知機能低下のリスクに及ぼす影響を系統的にレビューし、メタアナリシスを行うこと。
  • 認知機能転帰との関連について、個々の薬剤クラスを評価すること。

主な方法:

  • 2023年11月21日まで、3つのデータベースで包括的な検索を実施した。
  • 含まれた研究は、糖尿病治療薬の使用と認知機能転帰を評価したランダム化比較試験（RCT）、コホート研究、症例対照研究であった。
  • 個々の薬剤クラスについて、薬剤なし、プラセボ、または他の薬剤と比較してメタアナリシスを実施した。研究の質は確立された尺度を用いて評価した。

主要な成果:

  • グルカゴン様ペプチド-1受容体作動薬（GLP-1 RA）は、認知症のリスクを有意に低下させた（RCTでは53％、症例対照研究では27％）。
  • グリタゾンは、7つの縦断研究で異質性が観察されなかった（RR=0.78）認知症リスクの低下と関連していた。
  • メトホルミン、スルホニル尿素薬、インスリン、ジペプチジルペプチダーゼ-IV阻害薬（DPP-1V）は、認知症リスク低下との一貫した関連を示さなかった。多くの観察研究は、交絡因子によって限界があった。
キーワード:
糖尿病薬認知症リスクGLP-1 RAグリタゾンメトホルミン

さらに関連する動画

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.6K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

関連する実験動画

Last Updated: Jan 8, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
10:57

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children

Published on: August 22, 2012

24.2K
Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

2.6K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

結論:

  • ランダム化比較試験は、GLP-1 RAが糖尿病患者の認知症リスクを一貫して低下させることを示唆している。
  • グリタゾンも認知症に対する保護効果を一貫して示しており、一般的な適用可能性を示唆している。
  • メトホルミン、スルホニル尿素薬、インスリン、DPP-1V阻害薬に関する結果は一貫性がなく、用量、疾患重症度、治療期間を考慮したさらなる研究が必要であることが強調された。